期刊文献+

重组腺病毒介导Klotho基因转导对大鼠心力衰竭心肌重构的影响 被引量:12

Impact of transfection with recombinant adenovirus vector-mediated Klotho gene on myocardial remodeling in a rat model of heart failure
原文传递
导出
摘要 目的 探讨重组腺病毒介导的Klotho基因转染对大鼠心力衰竭(心衰)进程以及心肌重构的影响,并探讨其机制.方法 SPF级SD大鼠,随机数表法分为5组,即正常对照组(对照组,未给予任何干预),心衰组(只做心衰模型,不给予其他干预),生理盐水组(在心衰模型的基础上尾静脉注射生理盐水,0.5 ml/只),腺病毒载体介导的增强荧光蛋白组(Ad.EGFP组,在心衰模型的基础上用腺病毒载体介导增强荧光蛋白,2×1010 pfu,0.5 ml/只),以及腺病毒载体介导的目的基因组(Ad.Klotho组,在心衰模型的基础上用腺病毒载体介导目的基因,2×1010pfu,0.5 ml/只),每组5只.异丙肾上腺素连续腹腔注射法建立大鼠心衰模型.构建重组腺病毒载体pDC316-CMV-EGFP-rKlotho,标记为Ad.Klotho,并将其转导至相应的心衰大鼠模型.建模第6周,采用超声心动图测定各组大鼠的左心室射血分数(LVEF);多道生理记录仪测定各组大鼠血液动力学变化;检测各组大鼠心肌组织病理学改变;冰冻切片后镜下观察各组大鼠心肌组织荧光蛋白表达水平;实时荧光定量聚合酶链反应评估各组大鼠心肌组织中Klotho基因的表达水平,以及心肌纤维化相关因子Ⅰ型胶原和Ⅲ型胶原的表达水平;ELISA法检测各组大鼠血浆中B型利钠肽(BNP)的表达水平.结果 心衰组、生理盐水组、Ad.EGFP组和Ad.Klotho组大鼠心肌组织苏木素伊红染色均可见心肌细胞断裂、心肌间质增生、心肌细胞肥大和结构改变.对照组大鼠心肌组织病理切片未见上述改变.通过比较发现,Ad.Klotho组大鼠心肌纤维化程度、重构程度以及心肌细胞肥大程度均较心衰组、生理盐水组和Ad.EGFP组低.建模第6周,Ad.Klotho组和Ad.EGFP组大鼠心肌组织中仍可见EGFP绿色荧光表达,而对照组、心衰组和生理盐水组则未见.各组大鼠心肌组织中Klotho、胶原Ⅰ a1和Ⅲa1 mRNA均有表达.其中,对照组和Ad.Klotho组Klotho mRNA表达水平较高,与其他3组比较差异均有统计学意义(P均<0.05),而心衰组、生理盐水组和Ad.EGFP组间Klotho mRNA表达水平差异无统计学意义.心衰组、生理盐水组和Ad.EGFP组胶原Ⅰ a1、Ⅲa1 mRNA表达水平均较对照组和Ad.Klotho组高(P均< 0.05),且三组间比较差异无统计学意义.超声心动图结果示心衰组、生理盐水组、Ad.EGFP组和Ad.Klotho组大鼠总体LVEF为(42.27±3.22)%低于对照组的(72.13±2.97)%(P<0.01).对照组和Ad.Klotho组心率均高于心衰组、生理盐水组和Ad.EGFP组(P均<0.05).对照组和Ad.Klotho组左心室内压均高于心衰组、生理盐水组和Ad.EGFP组(P均<0.01).对照组和Ad.Klotho组左心室舒张末压均低于心衰组、生理盐水组和Ad.EGFP组(P均<0.01).对照组和Ad.Klotho组左心室内压最大上升速率(+dp/dtmax)均大于心衰组、生理盐水组和Ad.EGFP组(P均<0.05).对照组和Ad.Klotho组左心室内压最大下降速率(-dp/dtmax)亦均大于心衰组、生理盐水组和Ad.EGFP组(P均<0.05).心衰组、生理盐水组、Ad.EGFP组和Ad.Klotho组大鼠心脏体质量指数分别为(6.50±0.32)、(6.46±0.18)、(6.34±0.15)和(5.23±0.19) g×l 000/g均明显高于对照组(2.84±0.25)g×1 000/g,P均<0.05,但Ad.Klotho组又明显低于心衰组、生理盐水组和Ad.EGFP组(P<0.05),心衰组、生理盐水组和Ad.EGFP组间差异则无统计学意义.心衰组、生理盐水组、Ad.EGFP组和Ad.Klotho组大鼠血清中BNP水平均明显高于对照组(P均<0.01),但Ad.Klotho组明显低于心衰组、生理盐水组和Ad.EGFP组(P均<0.05).结论 腹腔注射异丙肾上腺素可成功建立大鼠心衰模型.Klotho基因可抑制心肌纤维化、心肌肥大及胶原纤维增生. Objective To assess the impact of transfection with recombinant adenovirus vector-mediated Klotho gene on myocardial remodeling in a rat model of heart failure (HF) by intraperitoneal injection of isoproterenol.Methods Rats were divided into 5 groups by table of exponential random numbers:normal control group,HF group,saline-control HF group,recombinant adenovirus vector transfection group (Ad.EGFP group,2 × 1010 pfu,0.5 ml/rat),pDC316-CMV-EGFP-rKlotho transfection group (Ad.Klotho group,n =5 each).Left ventricular ejection fraction (LVEF) was obtained by echocardiography,hemodynamic parameters obtained by multi-channel physiological recorder,myocardial tissue underwent pathohistological examination.Additionally,the green fluorescin expression was observed on frozen heart section.Myocardial fibrosis correlated gene expression including Klotho gene,collagen Ⅰ and Ⅲ was detected by real time-PCR.Moreover,plasma levels of B-type natriuretic peptide (BNP) were measured with ELISA.Results Compared to saline control HF group,LVEF,LVSP and ± dp/dtmax were significantly increased,myocardial fibrosis and myocardial remodeling were significantly attenuated in the Ad.Klotho group and there was green fluorescin distribution in myocardial tissues of Ad.Klotho group.Klotho expression was down-regulated and collagen Ⅰ and Ⅲ expression was upregulated in HF rats compared to normal control group (all P < 0.05) and these changes could be significantly reversed in Ad.Klotho group (all P < 0.05).Plasma BNP level was also significantly lower in Ad.Klotho group than in HF group (P < 0.05).Conclusions Klotho gene transfection could improve cardiac function and attenuate cardiac remodeling and reducing myocardial fibrosis.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2015年第3期219-226,共8页 Chinese Journal of Cardiology
基金 成都军区昆明总医院院管课题(2012YG15)
关键词 心力衰竭 充血性 心室重构 KLOTHO基因 Heart failure, congestive Ventricular remodeling Gene, Klotho
  • 相关文献

参考文献23

  • 1Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing [J]. Nature, 1997, 390( 6655) :45-51.
  • 2Lim K, Lu TS, Molostvov G, et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23 [J] . Circulation, 2012,125(18) :2243-2255.
  • 3Cheek ID, Wirrig EE, Alfieri CM, et al. Differential activation of valvulogenic, chondrogenic, and osteogenic pathways in mouse models of myxomatous and calcific aortic valve disease [J] . 1 Mol Cell Cardiol, 2012, 52(3) :689-700.
  • 4Hu MC, Shi M, Zhang 1, et al. Klotho deficiency causes vascular calcification in chronic kidney disease [J]. 1 Am Soc Nephrol, 2011 , 22 (1) :124-136.
  • 5Xie 1, Cha SK, An SW, et al. Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart [J]. Nat Commun, 2012, 3:1238.
  • 6Kuro-o M. Klotho as a regulator of oxidative stress and senescence [J]. Bioi Chern, 2008, 389(3) :233-241.
  • 7Kokkinaki M, Abu-Asab M, Gunawardena N, et al. Klotho regulates retinal pigment epithelial functions and protects against oxidative stress[J].J Neurosci, 2013, 33(41) :16346-16359.
  • 8Shimada T, Takeshita Y, Murohara T, et al. Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse [IJ. Circulation, 2004,110(9) :1148-1155.
  • 9Kilkenny C, Browne W, Cuthill IC, et al. Animal research: reporting in vivo experiments: the ARRIVE guidelines [J]. Br J Pharmacol, 2010,160(7) :1577-1579.
  • 10McGrath rc, Drummond GB, McLachlan EM, et al. Guidelines for reporting experiments involving animals: the ARRIVE guidelines[J]. Br 1 Pharmacol, 2010,160(7) :1573-1576.

同被引文献89

引证文献12

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部